(Greenville, South Carolina) – October 9, 2019 – ChartSpan, the largest fully-managed chronic care management company in the United States, has appointed Gordon Crenshaw as a Board Observer. Gordon is currently a Principal at Blue Heron Capital, where he focuses on working with healthcare and technology-enabled businesses. Blue Heron Capital is part of the five-investor syndicate involved in ChartSpan’s recent Series A round of capital.
Prior to his time at Blue Heron Capital, Gordon was an investor at the University of Virginia Investment Management Company (UVIMCO). He also spent time at Brazos Private Equity Partners, a Dallas-based investment firm specializing in leveraged acquisitions and recapitalizations in the middle market. Gordon earned his Master of Business Administration from The Wharton School of the University of Pennsylvania.
In addition to his role with ChartSpan, Gordon currently represents Blue Heron Capital as a Board Observer for Stratasan, a leading provider of analytics software and services for hospital systems.
“Gordon Crenshaw’s financial expertise will help us drive growth in the right direction,” commented Jon-Michial Carter, CEO of ChartSpan. “We are excited to receive his thoughtful guidance, and the support of the entire Blue Heron network, as we expand our company nationally.”
“ChartSpan represents an attractive opportunity for Blue Heron,” said Gordon Crenshaw, Blue Heron Principal. “We often look for services and solutions in Healthcare that help reduce costs and deliver better patient outcomes, and ChartSpan’s innovative solution does just that. We are excited about the opportunity to support Jon-Michial and the rest of the ChartSpan team as they continue with their impressive growth.”
